Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03338569 · ClinicalTrials.gov registry record · Phase 2
Vitamin C and Septic Shock
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT03338569 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 125 participants.
The verdict
NCT03338569, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled clinical trial to compare Vitamin C versus placebo for patients presenting to the ICU with a diagnosis of septic shock.
Interventions
- DRUG Placebo
- DRUG Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-12-20 |
| Est. Completion | 2020-08-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03338569
The ClinicalTrials.gov registry entry for NCT03338569 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03338569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03338569 about?
NCT03338569 is a clinical study titled "Vitamin C and Septic Shock". This is a randomized, double-blind, placebo-controlled clinical trial to compare Vitamin C versus placebo for patients presenting to the ICU with a diagnosis of septic shock.
What is the current status of trial NCT03338569?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2017-12-20. Estimated completion is 2020-08-10.
What interventions are being tested in trial NCT03338569?
The interventions under investigation include: Placebo (DRUG), Vitamin C (DRUG).
Who is sponsoring clinical trial NCT03338569?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.